Beacon Bispecific

Use the complete Bispecific antibody clinical trial and drug landscape to your advantage

What we cover

This database solution is manually curated by sector-specific scientists and includes clinical trial and drug records for preclinical, active, approved, and discontinued antibody-based drugs that are designed to bind to two or more target antigens. We also cover:

  • Whole Antibodies
  • Antibody Fragments
  • Augmented Antibodies
  • Bispecific Fusion Proteins

How Beacon helps

Here are a few example use cases that have benefitted our clients in accelerating their Bispecific development programs:

  • Benchmark drug development and clinical trial strategies against competitors.
  • Getting an in-depth competitive landscape overview of the competitors and their assets in the clinic.
  • Drastically reduce manual research time with our database solution which allows users to rapidly assemble data for analysis on phase distributiontargets, disease indication, drug discontinuations and much more.
  • Identify new players and new assets entering the clinic and monitor their progress.

How Beacon Bispecific works

Search the clinical trial and drug landscape by multiple targets, scaffold and over 80 different bispecific formatsinstantaneously and/or extract the data points you need to conduct more complex analysis.

How we source the data for Bispecific/Multispecific Therapies

We house all publicly available sources of data updated with 24 – 48 hours of publication proactively.  Our sources cover (but are not limited to):

  • Clinical trials registries
  • Scientific journals and publications
  • Company reports and presentations
  • Press releases
  • Conference reports and abstracts
  • Government and regulatory organizations
  • Newspapers and other media
  • Patents

Related content

Bispecific Infographic 2021

Find out more

Bispecific Webinar 2020

Find out more

Bispecific Infographic 2020

Find out more

What our customers say

"I’ve rarely seen such dedication from a service provider in understanding and responding to our needs"

Competitive Intelligence Manager
Bispecific Drug Developer

Our Bispecific Expert

Beacon Bispecific Researcher

Shailee Patel is the lead research analyst for Bispecifics in the Beacon Targeted Therapies teams.

Sign up for her weekly newsletter with the latest Bispecific landscape with data from Beacon Bispecific.

Subscribe to newsletter

Other Beacon Solutions

ADC
Adoptive Cell
Cancer Vaccine
Checkpoint
Cytokine
DDR
Gene Therapy
RNA
Oncolytic Viruses
TPD
Beacon ADC Logo

 

Covering all Antibody Drug Conjugates (ADCs), Small Molecule Drug Conjugates (SMDCs), Protein Drug Conjugates (PDCs), Immunotoxins and more

Find out more

Beacon Adoptive Cell Logo

 

Covering all engineered and non-engineered immune cell therapies, including CAR-T, TCR, NK, TILs, Gamma-Delta T Cells and more

Find out more

Cancer Vaccine Logo 2021

 

Beacon Cancer Vaccine provides the solution you need to master the prophylactic and therapeutic cancer vaccines field.

Find out more

Beacon Checkpoint Logo

 

Covering all Immune Checkpoint Combination Trials and Immune Checkpoint Modulators in development across 27 different checkpoint targets

Find out more

 

Covering all cytokines and drugs that target a cytokine or its immediate receptor belonging to the Interleukins, Interferons, Colony-stimulating factors, Transforming growth factor β, Tumour necrosis factor and Chemokines families.

Find out more

Beacon DDR Logo

 

Beacon DDR steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the DDR field.

Find out more

Beacon Gene Therapy Logo

 

From gene-editing technologies, novel delivery systems, and a variety of genetic materials being used- Beacon Gene Therapy steps into the field to give drug developers a precise and detailed view of how the gene therapy landscape looks.

Find out more

 

Covering Oligonucleotide-based, mRNA-Based, Ribozyme, and gRNA-Mediated Gene Editing therapies, as well as RNA-Targeted Small Molecules – Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space.

Find out more

Beacon Oncolytic Viruses Logo

 

From capturing viral family and strains to understanding any genetic modifications – Beacon Oncolytic Viruses steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the Oncolytic Virus field.

Find out more

Beacon TPD Logo

 

Beacon TPD provides the solution you need to master the targeted protein degradation field.

Find out more

Any questions? Contact us

To learn more about how we can tailor Beacon Bispecific to help you, get in touch with our sales team

Raj Kumar

 

Raj Kumar

Bispecific Sales Director

Contact us

About Beacon Targeted Therapies

We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.

logo